Black Rock Inc. Landec Corp \Ca\ Transaction History

Black Rock Inc.

  • $4.23 Trillion
  • Q1 2024

A detailed history of Black Rock Inc. transactions in Landec Corp \Ca\ stock. As of the latest transaction made, Black Rock Inc. holds 478,816 shares of LNDC stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
478,816
Previous 599,300 20.1%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024
SELL
N/A
-120,484 Reduced 20.1%
478,816 $0
Q4 2023

Feb 13, 2024
BUY
N/A
87,873 Added 17.18%
599,300 $0
Q3 2023

Nov 13, 2023
SELL
N/A
-20,616 Reduced 3.87%
511,427 $0
Q2 2023

Aug 11, 2023
SELL
N/A
-1,366,452 Reduced 71.98%
532,043 $0
Q1 2023

May 12, 2023
BUY
N/A
50,342 Added 2.72%
1,898,495 $0
Q4 2022

Feb 13, 2023
BUY
$0.0 - $9.95 $0 - $407,024
40,907 Added 2.26%
1,848,153 $0
Q3 2022

Nov 14, 2022
SELL
$8.57 - $11.57 $812,230 - $1.1 Million
-94,776 Reduced 4.98%
1,807,246 $16.1 Million
Q2 2022

Aug 12, 2022
BUY
$8.84 - $11.64 $82,600 - $108,764
9,344 Added 0.49%
1,902,022 $19 Million
Q1 2022

May 12, 2022
SELL
$10.07 - $11.93 $541,564 - $641,595
-53,780 Reduced 2.76%
1,892,678 $21.9 Million
Q4 2021

Feb 10, 2022
SELL
$7.95 - $11.24 $1.32 Million - $1.86 Million
-165,724 Reduced 7.85%
1,946,458 $21.6 Million
Q3 2021

Nov 09, 2021
SELL
$9.22 - $12.44 $859,552 - $1.16 Million
-93,227 Reduced 4.23%
2,112,182 $19.5 Million
Q2 2021

Aug 11, 2021
BUY
$9.91 - $12.78 $21.9 Million - $28.2 Million
2,205,409 New
2,205,409 $24.8 Million

Others Institutions Holding LNDC

# of Institutions
80
Shares Held
21.6M
Call Options Held
114K
Put Options Held
82.1K
View Full List

About LANDEC CORP \CA\

LNDC Quotes by TradingView
  • Ticker LNDC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 29,595,600
  • Description
  • Landec Corporation operates as a diversified health and wellness company. The company manufactures pharmaceutical-grade sodium hyaluronate (HA)-based biomaterials for primary use in the ophthalmic and orthopedic markets. It also provides product development services to its partners for HA-based, as well as non-HA based, aseptically formulated, a...
More about LNDC
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email